Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lin-benzoaristeromycin.

V P Rajappan1, S W Schneller

  • 1Department of Chemistry, Auburn University, Auburn, Alabama 36849, USA.

Nucleosides, Nucleotides & Nucleic Acids
|September 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues.

Antiviral chemistry & chemotherapy·2002
Same author

5'-Nor carbocyclic 5'-deoxy-5'-(isobutylthio)adenosine and a 2',3'-dideoxy-2',3'-didehydro derivative.

Antiviral chemistry & chemotherapy·2001
Same author

Carbocyclic 5'-noruridine.

Nucleosides, nucleotides & nucleic acids·2000
Same author

Investigations into biochemical mode of inhibition of guanase by azepinomycin: synthesis and biochemical screening of several analogues of azepinomycin.

Nucleosides & nucleotides·1999
Same author

Analogues of azepinomycin as inhibitors of guanase.

Nucleosides & nucleotides·1998
Same author

The importance of the 4'-hydroxyl hydrogen for the anti-trypanosomal and antiviral properties of (+)-5'-noraristeromycin and two 7-deaza analogues.

Bioorganic & medicinal chemistry·1998
Same journal

LncRNA EGOT inhibits the proliferation of lung adenocarcinoma cells and is associated with poor prognosis.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Can the combination of 5-fluorouracil and gemcitabine increase the treatment efficacy of pancreatic and colon cancer?

Nucleosides, nucleotides & nucleic acids·2026
Same journal

"Aptamer-guided therapeutics and diagnostics for metabolic syndrome: Design, delivery, and translation of aptamer-based systems".

Nucleosides, nucleotides & nucleic acids·2026
Same journal

The impact of vitamin B12 deficiency on urinary profile of <i>de novo</i> purine synthesis intermediates: consequences of the methylfolate trap.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Evaluation of MTH1 and DCTPP1 inhibitors in fluorocyclopentenylcytosine (RX-3117) resistant lung cancer cells and potential cross resistance patterns.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Circular RNAs: promising biomarkers for diagnosis, prognosis and therapy in oral squamous cell carcinoma.

Nucleosides, nucleotides & nucleic acids·2026
See all related articles

Researchers synthesized and analyzed the antiviral properties of a linear extended derivative of aristeromycin. This compound shows potential for development as a novel antiviral agent.

Area of Science:

  • Medicinal Chemistry
  • Virology
  • Organic Synthesis

Background:

  • Aristeromycin is a known nucleoside analog with antiviral activity.
  • Modifications of nucleoside analogs can lead to compounds with improved or altered biological properties.
  • Linear extended derivatives offer a unique structural modification for exploring structure-activity relationships.

Purpose of the Study:

  • To synthesize a novel linear extended derivative of aristeromycin.
  • To evaluate the in vitro antiviral activity of the synthesized compound.
  • To establish a foundation for further development of aristeromycin analogs.

Main Methods:

  • Chemical synthesis of the linear extended aristeromycin derivative.
  • Purification and characterization of the synthesized compound using spectroscopic techniques.

Related Experiment Videos

  • Antiviral assays to determine the efficacy against selected viruses.

    • Main Results:

    • Successful synthesis of the target linear extended aristeromycin derivative.
    • Demonstration of significant antiviral activity of the compound against specific viral strains.
    • Identification of structure-activity relationships through comparative analysis.

    Conclusions:

    • The synthesized linear extended aristeromycin derivative possesses notable antiviral properties.
    • This compound represents a promising lead for the development of new antiviral therapeutics.
    • Further investigation into the mechanism of action and broader antiviral spectrum is warranted.